Compare CPHC & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPHC | ZTEK |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 72.4M |
| IPO Year | 1994 | N/A |
| Metric | CPHC | ZTEK |
|---|---|---|
| Price | $15.40 | $0.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.5K | ★ 47.2K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,099,604.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2225.73 |
| 52 Week Low | $14.39 | $0.62 |
| 52 Week High | $22.07 | $1.84 |
| Indicator | CPHC | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | 37.05 |
| Support Level | $15.10 | $0.64 |
| Resistance Level | $15.31 | $0.75 |
| Average True Range (ATR) | 0.18 | 0.04 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 100.00 | 10.42 |
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.